EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Positive Inotropic Agents in Cancer Therapy: Exploring Potential Anti-Tumor Effects

Eduarda Ribeiro, Nuno Vale

Targets · 2024

DOI: 10.3390/targets2020009 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Targets, 2024. Verfasst von Eduarda Ribeiro und 1 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 156 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundo Europeu de Desenvolvimento Regional (FEDER), Portuguese fund CHAIR in Onco-Innovation from the Faculty of Medicine of the University of Porto (FMUP).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cancer remains a significant global health challenge despite advancements in diagnosis and treatment. Traditional cancer therapies often face limitations such as toxicity and drug resistance. Drug repurposing has emerged as a promising strategy to overcome these challenges by identifying new therapeutic uses for existing drugs. This review explores the potential of repurposing positive inotropic agents, which are traditionally used in cardiovascular medicine, for cancer therapy. Positive inotropic agents, including cardiac glycosides, β-agonists, phosphodiesterase inhibitors, and calcium sensitizers have shown preclinical evidence of anti-tumor activity through various mechanisms, such as modulation of the intracellular signaling pathways, increasing cyclic adenosine monophosphate (cAMP) levels, the production of nitric oxide, and decreasing reactive oxygen species levels. Despite the absence of specific clinical trials in this area, these findings suggest a promising avenue for further research and development of combination therapies to improve cancer treatment outcomes. However, challenges such as elucidating specific anti-tumor mechanisms, identifying predictive biomarkers, and optimizing safety profiles need to be addressed to fully realize the therapeutic potential of positive inotropic agents in oncology.

Förderung

  • Fundo Europeu de Desenvolvimento Regional (FEDER)
  • Portuguese fund CHAIR in Onco-Innovation from the Faculty of Medicine of the University of Porto (FMUP)

Zitieren

APA

Ribeiro, E., & Vale, N. (2024). Positive Inotropic Agents in Cancer Therapy: Exploring Potential Anti-Tumor Effects. Targets. https://doi.org/10.3390/targets2020009

Vancouver

Ribeiro E, Vale N. Positive Inotropic Agents in Cancer Therapy: Exploring Potential Anti-Tumor Effects. Targets. 2024. doi:10.3390/targets2020009

BibTeX
@article{Ribeiro2024,
  author = {Ribeiro, Eduarda and Vale, Nuno},
  title = {Positive Inotropic Agents in Cancer Therapy: Exploring Potential Anti-Tumor Effects},
  journal = {Targets},
  year = {2024},
  doi = {10.3390/targets2020009}
}
Kostenlos starten →